Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
SCTID: 1119350007, Defined, Active
1119350007|Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)|
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid
- en Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure)
- en Severe acute respiratory syndrome coronavirus 2 mrna vaccination
- en 2019-ncov mrna immunisation
- en 2019-ncov mrna immunization
- en 2019-ncov mrna vaccination
- en 2019 novel coronavirus mrna immunisation
- en 2019 novel coronavirus mrna immunization
- en 2019 novel coronavirus mrna vaccination
- en Administration of sars-cov-2 mrna vaccine
- en Covid-19 mrna immunisation
- en Covid-19 mrna immunization
- en Covid-19 mrna vaccination
- en Sars-cov-2 mrna immunisation
- en Sars-cov-2 mrna immunization
- en Sars-cov-2 mrna vaccination